Plain-English translation of NCT07502664 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is an observational study designed to test and refine new vision assessments for people with inherited retinal diseases—conditions like retinitis pigmentosa and Stargardt disease that progressively damage vision. Rather than testing a new medication, researchers are evaluating whether new vision tests accurately measure how well people can see and function in daily life, particularly their ability to navigate and move around safely.
Current vision tests may not capture how well people with these eye diseases can actually move around, find their way, and perform daily activities. This study aims to develop better, more practical vision tests that reflect real-world function and could be used in future clinical trials to measure whether new treatments truly help patients.
You likely qualify if…
You likely don't qualify if…
You will complete a series of vision tests and navigation tasks designed to measure how your peripheral vision affects your real-world function. This is a non-interventional study, meaning you won't receive any new medication or treatment—researchers will simply assess how well existing vision tests work in people with your condition. The specific number and duration of visits will depend on the study's design, but you should expect appointments focused on vision testing and practical mobility assessments.
AI-generated summary from trial data · Jun 3, 2026 · Not medical advice
United States
Sponsor
Ray Therapeutics, Inc.
Enrollment target
~25 participants
Started
February 2026
Primary completion
February 2027
Age range
18 Years and older
Last updated on clinicaltrials.gov in March 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Reem Jaber, MS, CGC
Ray Therapeutics, Inc.
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.